Literature DB >> 2282416

Early HIV infection: to treat or not to treat?

A M Swart, I Weller, J H Darbyshire.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2282416      PMCID: PMC1663958          DOI: 10.1136/bmj.301.6756.825

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Monitoring of lymphocyte subpopulation changes in the assessment of HIV infection.

Authors:  A G Bird
Journal:  Genitourin Med       Date:  1990-06

2.  Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.

Authors:  M A Fischl; D D Richman; D M Causey; M H Grieco; Y Bryson; D Mildvan; O L Laskin; J E Groopman; P A Volberding; R T Schooley
Journal:  JAMA       Date:  1989-11-03       Impact factor: 56.272

3.  HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

Authors:  B A Larder; G Darby; D D Richman
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

4.  The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Authors:  M A Fischl; D D Richman; N Hansen; A C Collier; J T Carey; M F Para; W D Hardy; R Dolin; W G Powderly; J D Allan
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391

5.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

  5 in total
  7 in total

Review 1.  Infectious diseases and AIDS.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

2.  Disseminated cytomegalovirus infection.

Authors:  A Grant; C Sargent; I V Weller; F Scaravilli; L Michaels; R F Miller
Journal:  Genitourin Med       Date:  1992-04

3.  Early HIV infection.

Authors:  M Walker
Journal:  BMJ       Date:  1990-10-27

Review 4.  Will we ever know when to treat HIV infection?

Authors:  A N Phillips; G D Smith; M A Johnson
Journal:  BMJ       Date:  1996-09-07

5.  Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.

Authors:  C A Lee; A N Phillips; J Elford; G Janossy; P Griffiths; P Kernoff
Journal:  BMJ       Date:  1991-11-02

6.  Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS.

Authors:  R B Nieman; J Fleming; R J Coker; J R Harris; D M Mitchell
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

7.  Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS.

Authors:  B S Peters; E J Beck; D G Coleman; M J Wadsworth; O McGuinness; J R Harris; A J Pinching
Journal:  BMJ       Date:  1991-01-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.